Sealeo is on a mission to eliminate waste in the pharmaceutical industry by revolutionizing last-mile vaccine delivery.
Currently, 50% of vaccines are wasted globally, releasing 2.5 million tonnes of CO2 and claiming the lives of 2-3 million children annually.
The main reason for this wastage is inadequate packaging solutions that fail to address the unique challenges of last-mile delivery.
On top of this, current solutions continue to rely on materials such as polystyrene and synthetic coolants, which contribute 10 million tons of CO2 annually.
Sealeo offers a novel packaging material designed to keep vaccines cold passively, effectively, and affordably. Our fully biodegradable, cost-effective, and lightweight material offers unparalleled adaptability. Its flexibility and moldability allow it to be custom-shaped to the exact dimensions of the medicine being transported, boosting efficiency in last-mile delivery and significantly reducing greenhouse gas emissions.
Company Details
Sealeo Questions
Sealeo's LinkedIn profile is https://uk.linkedin.com/company/sealeo
Sealeo has
6 employees.
View email and phone details for 6
employees at Sealeo.
Sealeo's industry is
Biotechnology Research
Sealeo's top competitors are
Treeva,
Biofonic,
Ponda,
Egodziny,
Nextract Energy,
Tera Mira,
Sequinova,
Ventrix Labs,
Dotplot,
Even.
Sealeo's categories are Biotechnology Research
Sealeo's founding year is 2024
